Role of the Fibroblast Activation Protein (FAP) as Biomarker of Fibrotic Lung Diseases
Status: Recruiting
Location: See location...
Intervention Type: Diagnostic test
Study Type: Interventional
Study Phase: Phase 2
SUMMARY
To evaluate the effect of an anti-fibrotic treatment initiation on the fibrotic activity as assessed by FAPI PET/CT.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Adults patients with a fibrotic lung disease (idiopathic pulmonary fibrosis (IPF) or non-IPF fibrotic ILD) as defined according to the 2022 ATS/ERS/JRS/ALAT Clinical Practice Guidelines
Locations
Other Locations
Belgium
Medecine
RECRUITING
Brussels
Contact Information
Primary
Benjamin Bondue
benjamin.bondue@hubruxelles.be
+ 32 (2) 555 5758
Time Frame
Start Date: 2023-03-09
Estimated Completion Date: 2027-03-09
Participants
Target number of participants: 70
Related Therapeutic Areas
Sponsors
Leads: Erasme University Hospital